Medscape36m
FDA OKs First-in-Class Antipsychotic for Schizophrenia
The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.
Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung'
The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a ...
You're Probably Eating Way Too Much Salt. Here's How to Tell.
Americans are eating too much salt. According to the FDA, Americans eat on average about 3,400 mg of sodium per day—more than ...
The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment
The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated ...
The American Journal of Managed Care55m
FDA Approves Dupilumab as First Biologic Treatment for COPD
The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary ...
The Hill40m
FDA approves new type of schizophrenia drug
The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, ...
Intermountain Medical Center first to use FDA-approved device to treat complex aortic aneurysms
Intermountain Medical Center in Murray has made medical history as the first hospital in the United States to perform a new ...
verywellhealth22m
Why You May Need an Ultrasound Test and What to Expect
An ultrasound gives providers a better view of internal organs. They’re used to help diagnose conditions and monitor ...
southernillinoisnow55m
FDA approves first new drug for schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...